newscientist.com

'Transformative' pancreatic cancer drug doubles survival time | New Scientist

People with advanced pancreatic cancer taking an experimental daily pill lived nearly twice as long as those receiving chemotherapy infusions

This site doesn’t allow embedding inside another page — open it in a new tab. Your Weird rating still works from the top bar.